Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

68.14

+0.77 (1.14%)

At close: Mar 9, 2026, 4:00 PM EDT

68.25

+0.11 (0.16%)

After-hours: Mar 9, 2026, 7:51 PM EDT

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $8.04 billion as of March 9, 2026. Its market cap has increased by 13.68% in one year.

Market Cap

8.04B

Enterprise Value

10.08B

1-Year Change

13.68%

Ranking

#1046

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $8.04B, an increase of 99,179.98%. That is a compound annual growth rate of 36.87%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	7.95B	0.46%
Dec 31, 2025	7.91B	30.11%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ImmunityBio	8.91B
Praxis Precision Medicines	8.65B
Vaxcyte	8.53B
ABIVAX Société Anonyme	8.49B
Bio-Techne	8.43B
Arrowhead Pharmaceuticals	8.38B
Axsome Therapeutics	8.30B
Nuvalent	7.82B

Market Cap Rankings